• HOME
  • EVENTS
  • MEMBERSHIP
  • LINKS
  • OFFICERS

ASA Home

NEW JERSEY CHAPTER



    Webinar (Slides), June 14, 2019

  • Hierarchical testing in a group sequential design with different information times, by Dong Xi, Novartis and Jiangtao Gou, Hunter College of CUNY

    Webinar (Slides), May 4, 2018

  • The Impact of Companion Diagnostic Device Measurement Performance on Personalized Medicine Clinical Trial Designs, by Meijuan Li, CBER/FDA

    Webinar (Slides), April 5, 2018

  • Statistical Significance and the Dichotomization of Evidence, by Blakely McShane, Kellogg School of Management at Northwestern University

    Webinar (Slides), December 8, 2017

  • Randomized Trial Designs for Evaluating Predictive Biomarker Tests: What’s the Estimand?, by Gene Pennello, FDA/CDRH

    Webinar (Slides), October 6, 2017

  • How the ICH E9 addendum around estimands may impact our clinical trials, by Frank Bretz, Novartis (ICH E9(R1) Expert Working Group)

    Webinar (Slides), June 30, 2017

  • Improving Oncology Clinical Programs by use of Innovative Designs and Comparing them via Simulations, by Olga Marchenko, Vice President, Advisory Analytics, QuintilesIMS